|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Lyase
|
 |
|
Title:
|
 |
Anthranilate synthase from s. Marcescens
|
|
Structure:
|
 |
Anthranilate synthase. Chain: a, c. Synonym: anthranilate synthase trpe. Engineered: yes. Trpg. Chain: b, d. Synonym: anthranilate synthase trpg. Engineered: yes
|
|
Source:
|
 |
Serratia marcescens. Organism_taxid: 615. Expressed in: escherichia coli. Expression_system_taxid: 562. Expression_system_taxid: 562
|
|
Biol. unit:
|
 |
Tetramer (from
)
|
|
Resolution:
|
 |
|
1.95Å
|
R-factor:
|
0.181
|
R-free:
|
0.246
|
|
|
Authors:
|
 |
G.Spraggon,C.Kim,X.Nguyen-Huu,M.-C.Yee,C.Yanofsky,S.E.Mills
|
Key ref:
|
 |
G.Spraggon
et al.
(2001).
The structures of anthranilate synthase of Serratia marcescens crystallized in the presence of (i) its substrates, chorismate and glutamine, and a product, glutamate, and (ii) its end-product inhibitor, L-tryptophan.
Proc Natl Acad Sci U S A,
98,
6021-6026.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
10-Mar-01
|
Release date:
|
16-May-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B, C, D:
E.C.4.1.3.27
- Anthranilate synthase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
Tryptophan Biosynthesis
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Chorismate + L-glutamine = anthranilate + pyruvate + L-glutamate
|
 |
 |
 |
 |
 |
Chorismate
|
+
|
L-glutamine
Bound ligand (Het Group name = )
matches with 90.00% similarity
|
=
|
anthranilate
Bound ligand (Het Group name = )
matches with 90.00% similarity
|
+
|
pyruvate
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
L-glutamate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
metabolic process
|
6 terms
|
 |
|
Biochemical function
|
catalytic activity
|
6 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
98:6021-6026
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
The structures of anthranilate synthase of Serratia marcescens crystallized in the presence of (i) its substrates, chorismate and glutamine, and a product, glutamate, and (ii) its end-product inhibitor, L-tryptophan.
|
|
G.Spraggon,
C.Kim,
X.Nguyen-Huu,
M.C.Yee,
C.Yanofsky,
S.E.Mills.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of anthranilate synthase (AS) from Serratia marcescens, a
mesophilic bacterium, has been solved in the presence of its substrates,
chorismate and glutamine, and one product, glutamate, at 1.95 A, and with its
bound feedback inhibitor, tryptophan, at 2.4 A. In comparison with the AS
structure from the hyperthermophile Sulfolobus solfataricus, the S. marcescens
structure shows similar subunit structures but a markedly different oligomeric
organization. One crystal form of the S. marcescens enzyme displays a bound
pyruvate as well as a putative anthranilate (the nitrogen group is ambiguous) in
the TrpE subunit. It also confirms the presence of a covalently bound glutamyl
thioester intermediate in the TrpG subunit. The tryptophan-bound form reveals
that the inhibitor binds at a site distinct from that of the substrate,
chorismate. Bound tryptophan appears to prevent chorismate binding by a
demonstrable conformational effect, and the structure reveals how occupancy of
only one of the two feedback inhibition sites can immobilize the catalytic
activity of both TrpE subunits. The presence of effectors in the structure
provides a view of the locations of some of the amino acid residues in the
active sites. Our findings are discussed in terms of the previously described AS
structure of S. solfataricus, mutational data obtained from enteric bacteria,
and the enzyme's mechanism of action.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Structure of the AS of S. marcescens. (a) Ribbon
diagram of the AS oligomer, TrpG subunits shown in blue, TrpE
subdomain I shown in green subdomain II in yellow. Striped
regions correspond to additional structure in S. marcescens
compared with that of S. solfataricus. Glutamyl, benzoate,
pyruvate, and tryptophan are shown as CPK models. (b) Stereo
diagram of the heterodimer; TrpG shown in lilac, TrpE in black;
regions of TrpG that move on addition of tryptophan relative the
C-crystal are shown in red, whereas those of TrpE are in yellow;
residues important to the CA-binding pocket (G328, T329, H398,
G485) are shown as light blue balls, residues involved in
pyruvate interactions (Y449, R469, G483) are in purple, residues
involved in magnesium coordination (E358,361, E495, E498) are
colored light purple, magnesium ion in orange, water molecules
in dark blue, Trp-binding residues (S40, P291, M293, V453, Y455)
are light green, and residues involved in glutamine binding
(P57, G58, G60, C85, L86, Q89, S135, S136) are in green.
Benzoate, pyruvate, magnesium, and glutamyl are shown as
ball-and-stick figures. Produced by BOBSCRIPT and RASTER 3D
(39-42).
|
 |
Figure 3.
Fig. 3. Substrate product and Trp-binding sites of the AS
molecule. Carbon atoms are dark gray, nitrogen blue, and oxygen
red. Electrostatic and hydrogen-bond interactions are shown as
black dotted lines. (a) Binding residues for glutamyl thioester
intermediate of TrpG. Glutamyl moiety drawn with cyan bonds. A
[A]-weighted
F[o] F[c] map
contoured at 3.5 SD is shown in transparent blue. (b) CA-binding
pocket, anthranilate, and pyruvate are drawn with dark red
bonds, magnesium ion in orange, ordered waters in cyan. A [A]-weighted
F[o] F[c] map
contoured at 3.0 SD is shown in transparent green. (c)
Trp-binding pocket, tryptophan shown in green. (d)
Conformational states associated with anthranilate, pyruvate,
and Trp-bound forms. The molecule is viewed with the molecular
2-fold perpendicular to the page (i.e., perpendicular to the
view in Fig. 2a). TrpG subunits shown in transparent blue, helixes
and loops involved in heterotetramer rearrangement shown as
rods, C-crystal representation shown in green rearrangement in
the T-crystal, shown in red. Tryptophan is shown as CPK model in
yellow. Produced by BOBSCRIPT and RASTER 3D (39-42).
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.M.Lipchock,
and
J.P.Loria
(2010).
Nanometer propagation of millisecond motions in V-type allostery.
|
| |
Structure, 18,
1596-1607.
|
 |
|
|
|
|
 |
R.J.Payne,
E.M.Bulloch,
O.Kerbarh,
and
C.Abell
(2010).
Inhibition of chorismate-utilising enzymes by 2-amino-4-carboxypyridine and 4-carboxypyridone and 5-carboxypyridone analogues.
|
| |
Org Biomol Chem, 8,
3534-3542.
|
 |
|
|
|
|
 |
R.J.Payne,
E.M.Bulloch,
M.M.Toscano,
M.A.Jones,
O.Kerbarh,
and
C.Abell
(2009).
Synthesis and evaluation of 2,5-dihydrochorismate analogues as inhibitors of the chorismate-utilising enzymes.
|
| |
Org Biomol Chem, 7,
2421-2429.
|
 |
|
|
|
|
 |
E.J.Hart,
and
S.G.Powers-Lee
(2008).
Mutation analysis of carbamoyl phosphate synthetase: does the structurally conserved glutamine amidotransferase triad act as a functional dyad?
|
| |
Protein Sci, 17,
1120-1128.
|
 |
|
|
|
|
 |
M.Morar,
A.A.Hoskins,
J.Stubbe,
and
S.E.Ealick
(2008).
Formylglycinamide ribonucleotide amidotransferase from Thermotoga maritima: structural insights into complex formation.
|
| |
Biochemistry, 47,
7816-7830.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.J.Wierckx,
H.Ballerstedt,
J.A.de Bont,
J.H.de Winde,
H.J.Ruijssenaars,
and
J.Wery
(2008).
Transcriptome analysis of a phenol-producing Pseudomonas putida S12 construct: genetic and physiological basis for improved production.
|
| |
J Bacteriol, 190,
2822-2830.
|
 |
|
|
|
|
 |
S.G.Van Lanen,
S.Lin,
and
B.Shen
(2008).
Biosynthesis of the enediyne antitumor antibiotic C-1027 involves a new branching point in chorismate metabolism.
|
| |
Proc Natl Acad Sci U S A, 105,
494-499.
|
 |
|
|
|
|
 |
D.E.Scott,
A.Ciulli,
and
C.Abell
(2007).
Coenzyme biosynthesis: enzyme mechanism, structure and inhibition.
|
| |
Nat Prod Rep, 24,
1009-1026.
|
 |
|
|
|
|
 |
O.Kerbarh,
A.Ciulli,
D.Y.Chirgadze,
T.L.Blundell,
and
C.Abell
(2007).
Nucleophile selectivity of chorismate-utilizing enzymes.
|
| |
Chembiochem, 8,
622-624.
|
 |
|
|
|
|
 |
S.Mouilleron,
and
B.Golinelli-Pimpaneau
(2007).
Conformational changes in ammonia-channeling glutamine amidotransferases.
|
| |
Curr Opin Struct Biol, 17,
653-664.
|
 |
|
|
|
|
 |
A.J.Harrison,
M.Yu,
T.Gårdenborg,
M.Middleditch,
R.J.Ramsay,
E.N.Baker,
and
J.S.Lott
(2006).
The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin, reveals it to be a salicylate synthase.
|
| |
J Bacteriol, 188,
6081-6091.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.M.Bulloch,
and
C.Abell
(2005).
Detection of covalent intermediates formed in the reaction of 4-amino-4-deoxychorismate synthase.
|
| |
Chembiochem, 6,
832-834.
|
 |
|
|
|
|
 |
R.J.Payne,
M.D.Toscano,
E.M.Bulloch,
A.D.Abell,
and
C.Abell
(2005).
Design and synthesis of aromatic inhibitors of anthranilate synthase.
|
| |
Org Biomol Chem, 3,
2271-2281.
|
 |
|
|
|
|
 |
R.J.Payne,
O.Kerbarh,
R.N.Miguel,
A.D.Abell,
and
C.Abell
(2005).
Inhibition studies on salicylate synthase.
|
| |
Org Biomol Chem, 3,
1825-1827.
|
 |
|
|
|
|
 |
F.A.Lunn,
and
S.L.Bearne
(2004).
Alternative substrates for wild-type and L109A E. coli CTP synthases: kinetic evidence for a constricted ammonia tunnel.
|
| |
Eur J Biochem, 271,
4204-4212.
|
 |
|
|
|
|
 |
M.Goto,
R.Omi,
N.Nakagawa,
I.Miyahara,
and
K.Hirotsu
(2004).
Crystal structures of CTP synthetase reveal ATP, UTP, and glutamine binding sites.
|
| |
Structure, 12,
1413-1423.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Schwarzenbacher,
A.M.Deacon,
L.Jaroszewski,
L.S.Brinen,
J.M.Canaves,
X.Dai,
M.A.Elsliger,
R.Floyd,
A.Godzik,
C.Grittini,
S.K.Grzechnik,
H.E.Klock,
E.Koesema,
J.S.Kovarik,
A.Kreusch,
P.Kuhn,
S.A.Lesley,
D.McMullan,
T.M.McPhillips,
M.D.Miller,
A.Morse,
K.Moy,
M.S.Nelson,
J.Ouyang,
R.Page,
A.Robb,
K.Quijano,
G.Spraggon,
R.C.Stevens,
H.van den Bedem,
J.Velasquez,
J.Vincent,
F.von Delft,
X.Wang,
B.West,
G.Wolf,
K.O.Hodgson,
J.Wooley,
and
I.A.Wilson
(2004).
Crystal structure of a putative glutamine amido transferase (TM1158) from Thermotoga maritima at 1.7 A resolution.
|
| |
Proteins, 54,
801-805.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.M.Byrnes,
and
V.L.Vilker
(2004).
Extrinsic factors potassium chloride and glycerol induce thermostability in recombinant anthranilate synthase from Archaeoglobus fulgidus.
|
| |
Extremophiles, 8,
455-462.
|
 |
|
|
|
|
 |
M.Goto,
R.Omi,
J.Hoseki,
N.Nakagawa,
I.Miyahara,
and
K.Hirotsu
(2003).
Expression, purification and preliminary X-ray characterization of CTP synthetase from Thermus thermophilus HB8.
|
| |
Acta Crystallogr D Biol Crystallogr, 59,
551-553.
|
 |
|
|
|
|
 |
A.Douangamath,
M.Walker,
S.Beismann-Driemeyer,
M.C.Vega-Fernandez,
R.Sterner,
and
M.Wilmanns
(2002).
Structural evidence for ammonia tunneling across the (beta alpha)(8) barrel of the imidazole glycerol phosphate synthase bienzyme complex.
|
| |
Structure, 10,
185-193.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.F.Parsons,
P.Y.Jensen,
A.S.Pachikara,
A.J.Howard,
E.Eisenstein,
and
J.E.Ladner
(2002).
Structure of Escherichia coli aminodeoxychorismate synthase: architectural conservation and diversity in chorismate-utilizing enzymes.
|
| |
Biochemistry, 41,
2198-2208.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
O.Mayans,
A.Ivens,
L.J.Nissen,
K.Kirschner,
and
M.Wilmanns
(2002).
Structural analysis of two enzymes catalysing reverse metabolic reactions implies common ancestry.
|
| |
EMBO J, 21,
3245-3254.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|